Journal article

ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies

Q Chen, S Langenbach, M Li, YC Xia, X Gao, MJ Gartner, EA Pharo, SM Williams, S Todd, N Clarke, S Ranganathan, ML Baker, K Subbarao, AG Stewart

Frontiers in Pharmacology | FRONTIERS MEDIA SA | Published : 2022

Abstract

Coronavirus disease 2019 (COVID-19) caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an acute respiratory disease with systemic complications. Therapeutic strategies for COVID-19, including repurposing (partially) developed drugs are urgently needed, regardless of the increasingly successful vaccination outcomes. We characterized two-dimensional (2D) and three-dimensional models (3D) to establish a physiologically relevant airway epithelial model with potential for investigating SARS-CoV-2 therapeutics. Human airway basal epithelial cells maintained in submerged 2D culture were used at low passage to retain the capacity to differentiate into ciliat..

View full abstract

Grants

Awarded by Australian Research Council


Funding Acknowledgements

This work was funded by grants from NHMRC (1181637) and ARC (IC170100016) Industry Transformation Training Centre for Personalised Therapeutics Technologies, an MRFF/Stem Cells mission (MRF9200007) and the CSIRO Access2ACDP program. KS is supported by an NHMRC Investigator grant. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health.